Gyros Protein Technologies

Your guide to anti-AAV detection: Expert FAQs for preclinical and clinical success


FAQ

A practical reference for gene therapy professionals looking to streamline anti-AAV antibody testing and improve immunogenicity assessments across development phases.


If you have problems viewing the webinar, please contact maritha.lundin@gyrosproteintech.com

FILL IN FORM TO ACCESS THE FAQ